Parmax Pharma - Quaterly Results

14 Feb 2024 Evaluate
The Sales for the quarter ended December 2023 of Rs. 13.27 million declined by -75.21% from Rs. 53.53 millions.The Net Loss for the quarter ended December 2023 is Rs. -17.53 millions as compared to Net Profit of Rs. 17.44 millions of corresponding quarter ended December 2022Operating profit Margin for the quarter ended December 2023 slipped to -11.43% as compared to 23.28% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 13.27 53.53 -75.21 67.95 90.42 -24.85 154.24 182.51 -15.49
Other Income 0.11 0.09 22.22 0.34 0.25 36.00 0.40 0.63 -36.51
PBIDT -11.43 23.28 -149.10 -25.36 14.45 -275.50 22.93 26.21 -12.51
Interest 1.56 1.06 47.17 4.59 3.14 46.18 3.69 3.86 -4.40
PBDT -12.99 22.22 -158.46 -29.95 11.31 -364.81 19.24 22.35 -13.91
Depreciation 4.54 4.78 -5.02 13.05 14.06 -7.18 18.79 19.32 -2.74
PBT -17.53 17.44 -200.52 -43.00 -2.75 1463.64 0.45 3.03 -85.15
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.50 1.62 -7.41
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.35 -0.63 -44.44
PAT -17.53 17.44 -200.52 -43.00 -2.75 1463.64 -1.05 1.41 -174.47
Equity 37.41 37.41 0.00 37.41 37.41 0.00 37.41 37.41 0.00
PBIDTM(%) -86.13 43.49 -298.06 -37.32 15.98 -333.54 14.87 14.36 3.52

Parmax Pharma Share Price

29.20 -0.79 (-2.63%)
08-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6050.00
Cipla 1383.40
Zydus Lifesciences 1006.10
Lupin 1616.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.